Organic electroluminescent materials and devices

US9935276B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9935276-B2
Application numberUS-201313867750-A
CountryUS
Kind codeB2
Filing dateApr 22, 2013
Priority dateFeb 21, 2013
Publication dateApr 3, 2018
Grant dateApr 3, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Compounds including a ligand L according to Formula I devices containing the same and formulations including the same are described. In Formula I, B is a 5 or 6-membered carbocyclic or heterocyclic ring; C is a condensed aromatic ring system having at least two carbocyclic or heterocyclic rings; A-B represents a bonded pair of carbocyclic or heterocyclic rings coordinated to a metal M via a nitrogen atom in ring A and an sp 2 hybridized atom X 6 in ring B; R A , R B and R C can represent no substitutions or the maximum substitutions available on the respective ring; X 1 , X 2 , X 3 , X 4 , X 5 , and X 6 are carbon or nd nitrogen, and X 7 is carbon; at least one of R A and R C substituents adjacent to the bond between A and C is not hydrogen; and the ligand is coordinated to a metal, having an atomic number greater than 40.

First claim

Opening claim text (preview).

We claim: 1. A heteroleptic compound having a structure of Formula II: wherein n is 1 or 2; wherein B is a 5 or 6-membered carbocyclic or heterocyclic ring; wherein C is a condensed aromatic ring system having at least two carbocyclic or heterocyclic rings; wherein A-B represents a bonded pair of carbocyclic or heterocyclic rings coordinated to Ir via a nitrogen atom in ring A and an sp 2 hybridized atom X 6 in ring B; wherein A-C represents a bonded pair of carbocyclic or heterocyclic rings; wherein R A may represent mono, di, or tri substitutions, or no substitution; wherein R B may represent any number of substitution from mono to up to the maximum possible number of substitution on ring B, or no substitution; wherein R C may represent any number of substitution from mono to up to the maximum possible number of substitution on ring C, or no substitution; wherein each R A , R B , and R C is independently selected from the group consisting of hydrogen, deuterium, halide, alkyl, cycloalkyl, heteroalkyl, aralkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acids, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof; wherein X 1 , X 2 , X 3 , and X 4 are selected from C—R A , C—X 7 , and N; wherein X 6 is selected from carbon and nitrogen; wherein X 5 and X 7 are carbon; wherein at least one of R A and R C is at least a mono-substitution; wherein at least one of R A and R C adjacent to the bond between A and C is not hydrogen; wherein L′ is monoanionic bidentate ligand selected from the group consisting of: and wherein: R′, R 2′ , R″, and R′″ are independently selected from the group consisting of hydrogen, alkyl, alkoxy, amino, alkenyl, alkynyl, aralkyl, aryl, and heteroaryl, X is selected from the group consisting of S, NZ, O, Se, BZ, CZZ′, and C═O, Z and Z′ are independently selected from the group consisting of hydrogen, alkyl, and aryl, and R′, R″, and R′″ can join to form one or more fused rings. 2. The compound of claim 1 , wherein A is pyridine. 3. The compound of claim 1 , wherein B is phenyl. 4. The compound of claim 1 , wherein only one of R A and R C adjacent to the bond between A and C is not hydrogen. 5. The compound of claim 1 , wherein the R A and R C adjacent to the bond between A and C are independently selected from the group consisting of hydrogen; deuterium; linear, branched and cyclic alkyl; and combinations thereof. 6. The compound of claim 1 , wherein the R A and R C adjacent to the bond between A and C are independently selected from the group consisting of hydrogen, deuterium, methyl, ethyl, propyl, 1-methylethyl, butyl, 1-methylpropyl, 2-methylpropyl, pentyl, 1-methylbutyl, 2-methylbutyl, 3-methylbutyl, 1,1-dimethylpropyl, 1,2-dimethylpropyl, 2,2-dimethylpropyl, cyclopentyl, cyclohexyl, and combinations thereof. 7. The compound of claim 4 , wherein the only one of R A and R C adjacent to the bond between A and C that is not hydrogen is selected from the group consisting of deuterium, methyl, ethyl, and combinations thereof. 8. The compound of claim 1 , wherein n=1. 9. The compound of claim 1 , wherein n=2. 10. The compound of claim 1 , where L′ is 11. The compound of claim 1 , wherein bond between A and C is formed between X 2 and X 7 . 12. The compound of claim 1 , wherein bond between A and C is formed between X 3 and X 7 . 13. The compound of claim 1 , wherein C is selected from the group consisting of: wherein A 1 to A 8 , Q 1 to Q 6 , B 1 to B 8 , J 1 to J 12 , K 1 to K 10 are independently selected from the group consisting of C and N; wherein X and Y are independently selected from the group consisting of O, S, NR 3′ , and CR 3″ R 3′″ ; and wherein R 3′ , R 3″ and R 3′″ are independently selected from the group consisting of hydrogen, deuterium, halide, alkyl, cycloalkyl, heteroalkyl, aralkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acids, ester, nitrile, isonitrile, sulfanyl, sulfanyl, sulfonyl, phosphino, and combinations thereof. 14. The compound of claim 1 , wherein C is selected from the group consisting of: 15. A compound selected from the group consisting of: 16. A first device comprising a first organic light emitting device, further comprising: an anode; a cathode; and an organic layer, disposed between the anode and the cathode, comprising a heteroleptic compound having a structure of Formula II: wherein n is 1 or 2; wherein B is a 5 or 6-membered carbocycl

Assignees

Inventors

Classifications

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9935276B2 cover?
Compounds including a ligand L according to Formula I devices containing the same and formulations including the same are described. In Formula I, B is a 5 or 6-membered carbocyclic or heterocyclic ring; C is a condensed aromatic ring system having at least two carbocyclic or heterocyclic rings; A-B repr…
Who is the assignee on this patent?
Universal Display Corp
What technology area does this patent fall under?
Primary CPC classification C07F15/0033. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Apr 03 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).